Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;98(7):1000-5.
doi: 10.1111/j.1349-7006.2007.00484.x. Epub 2007 Apr 23.

Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1

Affiliations

Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1

Raquel Mejías-Luque et al. Cancer Sci. 2007 Jul.

Abstract

Lewis antigens are terminal fucosylated oligosaccharides synthesized by the sequential action of several glycosyltransferases. The fucosyltransferases are the enzymes responsible for the addition of terminal fucose to precursor oligosaccharides attached to proteins or lipids. These oligosaccharides, defined as cell surface markers, have been implicated in different types of intercellular interactions and in adhesion and invasion processes. Transfection of HT-29/M3 colon cancer cells with the full length of human fucosyltransferase (FUT1), induces the synthesis of H type 2 and Lewis y antigens, associated with a decrease of sialyl-Lewis x. The capacity to develop primary tumors when cells were injected intrasplenically was similar in parental and FUT1-transfected cells, but the capacity to colonize the liver after spleen removal was significantly reduced in M3/FUT1 transfected cells. These results indicate that the expression of FUT1 induces changes in the metastatic capacity of HT-29/M3 colon cancer cells, as a consequence of the altered expression pattern of type 2 Lewis antigens. Also, an association between MUC5AC expression and the degree of gland differentiation in both primary splenic tumors and hepatic metastases was detected.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Expression of H type 2, Sialyl‐Lewis a (s‐Le a), and s‐Le x antigens in M3‐4b parental cells and C50‐6a/fucosyltransferase (FUT1)‐transfected cells detected by flow cytometry. (b) Treatment of C50‐6a/FUT1‐transfected cells with phenyl β‐D‐galactoside: Flow cytometry detection of H type 2 antigen, s‐Le a, and s‐Le x after 4 days of treatment. Marker 1 (M1) indicates the positive cells.
Figure 2
Figure 2
Binding of M3‐4b parental cells and C50‐6a/ fucosyltransferase (FUT1)‐transfected cells to E‐Selectin. The two cell lines were also incubated with anti‐s‐Le x (KM93) and anti‐s‐Le a (57/27) antibodies. **P = 0.05.
Figure 3
Figure 3
MUC5AC, and Le y expression in primary splenic tumors after the injection of M3‐4b parental cells and C50‐6a/FUT1‐transfected cells, detected by immunohistochemistry. Original magnification × 200.
Figure 4
Figure 4
H type 2 antigen, Sialyl‐Lewis a (s‐Le a), and s‐Le x expression in liver metastases after the intrasplenic injection of HT‐29/M3 and C50‐6a/FUT1 cells, detected by immunohistochemistry. Original magnification × 200.

Similar articles

Cited by

References

    1. Larsen RD, Ernst LK, Nair RP, Lowe JB. Molecular cloning, sequence, and expression of a human GDP‐L‐fucose: beta‐D‐galactoside 2‐alpha‐L‐fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA 1990; 87: 6674–8. - PMC - PubMed
    1. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human Secretor blood group alpha (1,2) fucosyltransferase gene (FUT2). Homozygosity for an enzyme–inactivating nonsense mutation commonly correlates with the non–secretor phenotype. J Biol Chem 1995: 270: 4640–9. - PubMed
    1. De Vries T, Knegtel RM, Holmes EH, Macher BA. Fucosyltransferases: structure/function studies. Glycobiology 2001; 11: 119R–28R. - PubMed
    1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301–14. - PubMed
    1. Le Pendu J, Marionneau S, Cailleau‐Thomas A, Rocher J, Moullac‐Vaidye B, Clement M. ABH and Lewis histo‐blood group antigens in cancer. APMIS 2001; 109: 9–31. - PubMed

Publication types